Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 9/13/23 → 10/13/23 |
Financiación
- Janssen Research and Development LLC: 11.094,00 US$
Start Up Costs Only: A Randomized, Double-Blind, Placebo-Controlled Phase 1/2a Study for Safety and Immunogenicity Evaluations of Various RSV.preF-based Vaccine Formulations in Adults Aged 60 Years and Older
- Greenberg, Richard (PI)
- Caudill, Timothy (CoI)
- Simmons, Christopher (CoI)